SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 116 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $8,000 | -97.8% | 571 | -96.7% | 0.00% | – |
| Q3 2014 | $364,000 | -64.7% | 17,254 | -50.2% | 0.00% | -100.0% |
| Q2 2014 | $1,032,000 | +17.8% | 34,655 | -5.0% | 0.00% | 0.0% |
| Q1 2014 | $876,000 | +36.9% | 36,465 | +16.0% | 0.00% | 0.0% |
| Q4 2013 | $640,000 | -52.3% | 31,437 | +10.6% | 0.00% | -50.0% |
| Q3 2013 | $1,342,000 | +20.5% | 28,428 | -2.9% | 0.00% | 0.0% |
| Q2 2013 | $1,114,000 | – | 29,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |